About Cytena
Cytena is a company based in Freiburg Im Breisgau (Germany) founded in 2014 was acquired by CELLINK in August 2019. Cytena has raised $4.59 million across 2 funding rounds from investors including CELLINK and High-Tech Gründerfonds. Cytena offers products and services including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS. Cytena operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
- Headquarter Freiburg Im Breisgau, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytena Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytena
Cytena offers a comprehensive portfolio of products and services, including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS.
Optimizes monoclonality proof and cell tracking in research.
Enables rapid dispensing of fluorescent cells for assays.
Facilitates powerful dispensing of unlabeled cells in workflows.
Automates washing and dispensing for reproducible lab processes.
People of Cytena
Unlock access to complete
Unlock access to complete
Funding Insights of Cytena
Cytena has successfully raised a total of $4.59M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.39 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cytena
Cytena has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CELLINK and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
3D bioprinters and bioinks are developed for research applications.
|
Locked | Locked | Locked |
Investor details for Cytena
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytena
Investment portfolio details for Cytena
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytena
Detailed financials for Cytena
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytena Comparisons
Peer comparison for Cytena
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytena
Cytena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops flow cytometry and cell sorting technology
|
|
| Locked | Locked | Locked |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| Locked | Locked | Locked |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
|
| Locked | Locked | Locked |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| Locked | Locked | Locked |
Cell and molecular-based diagnostics for cancer management are developed.
|
Detailed competitors of Cytena
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytena
Complete news archive for Cytena
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytena
Cytena was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Cytena is headquartered in Freiburg Im Breisgau, Germany. It is registered at Freiburg Im Breisgau, Baden-wurttemberg, Germany.
Cytena is a funded company, having raised a total of $4.59M across 2 funding rounds to date.
Founded in 2014, Cytena operates in the biotechnology sector focused on cell analysis tools. The cy-Clone device is utilized for separating individual cells, supporting biological drug development and genetic studies in cancer and stem cell research. An automated imaging system is integrated to encapsulate cells within droplets, enabling delivery to diverse substrates for further applications.
Cytena's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
Cytena offers UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS.
Cytena has 2 investors. Key investors include CELLINK, and High-Tech Gründerfonds.